Zusammenfassung
Wir schildern den Fall eines durch Terbinafin induzierten subakut-kutanen Lupus erythematodes (SCLE) in seinem klinischen, dermatohistopathologischen und immunserologischen Vollbild. Neben antinukleären Antikörpern (ANA) und positiven SS-A- (Ro-)AK ließen sich Anti-Histon-AK mit Spezifität für H1 und H3 nachweisen. Wir geben einen Überblick über die Literatur zum Terbinafin-induzierten SCLE und diskutieren den Nachweis von Antikörpern gegen Histon H1 und H3 als mögliches Kriterium zur Diagnose des medikamenteninduzierten SCLE.
Abstract
We report on a patient with terbinafine-induced SCLE covering clinical, histopathological and serological findings. Positive serological results included ANA, SS-A (Ro)-antibodies and anti-histone-antibodies with specificity for H1 and H3. The literature on terbinafine-induced SCLE is reviewed. We discuss H1- and H3-specific anti-histone antibodies as a possible diagnostic criterion of drug-induced SCLE.
Literatur
Bonsmann G, Schiller M, Luger TA, Ständer S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus, J Am Acad Dermatol 44:925–931
Bork K (1999) Arzneimittelinduzierter Lupus Erythematodes. In: Arzneimittelnebenwirkungen an der Haut, 2. Aufl. Schattauer, S 157–161
Braun-Falco O, Plewig G, Wolff HH (1996) Lupus-erythematodes-visceralis-artiges Syndrom. In: Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 750–751
Braun-Falco O, Plewig G, Wolff HH (1996) Subakut-kutaner Lupus erythematodes (SCLE). In: Dermatologie und Venerologie, 4. Aufl. Springer, Berlin Heidelberg New York Tokyo, S 741–742
Brooke R, Coulson IH, Al-Dawoud A (1998) Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 139:1132–1133
Brown CW, Deng JS (1995) Thiazide diuretics induce cutaneous lupus-like adverse reaction. J Toxicol Clin Toxicol 33:729–733
Callen JP, Hughes AP, Kulp-Shorten C (2001) Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol 137:1196–1198
Condon CA, Downs AMR, Archer CB (1998) Terbinafine-induced acute generalized exanthematous pustulosis. Br J Dermatol 138:709–710
Darken M, McBurney EI (1988) Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene. J Am Acad Dermatol 18(1Pt 1):38–42
Finlay A (1996) Why is Terbinafine so effective in onychomycosis? A pharmacokinetic and scientific rationale. Lamisil (Terbinafine) in onychomycosis: debates old and new, extended abstracts of a satellite symposium held at the Fifth Congress of the European Academy of Dermatology and Venereology, 14 Oct. 1996, Lisbon, Portugal, pp 6–7
Ghate JV, Turner ML, Rudek MA et al. (2001) Drug-induced lupus associated with COL-3: report of three cases. Arch Dermatol 137:471–474
Gupta AK, Porges AJ (1998) Hypersensitivity syndrome reaction to oral terbinafine. Australas J Dermatol 39:171–172
Gupta AK, Lynde CW, Lauzon GJ et al. (1998) Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 138:529–532
Le Guayadec T, Saint-Blancard P, Bosonnet S et al. (2000) Oral terbinafine-induced plantar pustular psoriasis. Ann Dermatol Venereol 127:279–281
Miyagawa S, Okuchi T, Shiomi Y, Sakamoto K (1989) Subacute lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 21(2 Pt 2):343–346
Parodi A, Drosera M, Barbieri L, Rebora A (1995) Antihistone antibodies in scleroderma. Dermatology 191:16–18
Richert B, Uhoda I, De La Brassinne M (2001) Hair loss after terbinafine treatment. Br J Dermatol 145:842
Shapiro M, Li LJ, Miller J (1999) Terbinafine-induced neutropenia. Br J Dermatol 140:1196–1197
Sontheimer RD, Thomas JR, Gilliam JN (1979) Subacute cutaneous lupus erythematosus subset. Arch Dermatol 115:1409–1415
Vivas S, Rodriguez M, Palacio MA et al. (1997) Acute hepatitis associated with terbinafine. Gastroenterol Hepatol 20:456–458
Weedon D (1998) Subacute lupus erythematosus. Skin pathology. Churchill, Livingstone, pp 46–47
Interessenkonflikt:
Der korrespondierende Autor versichert, dass keine Verbindungen mit einer Firma, deren Produkt in dem Artikel genannt ist, oder einer Firma, die ein Konkurrenzprodukt vertreibt, bestehen.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Matthes, T., Hagedorn, M. Terbinafin-induzierter subakut-kutaner Lupus erythematodes. Hautarzt 55, 653–657 (2004). https://doi.org/10.1007/s00105-004-0731-6
Issue Date:
DOI: https://doi.org/10.1007/s00105-004-0731-6